Showing results (61-70 of 1,318) with videos related to
Sort By:
Pageof 132
Expert Review of Neurotherapeutics|October 4, 2017
Valbenazine for the treatment of tardive dyskinesiaThomas MüllerTranslational Neurodegeneration|December 6, 2012
Drug therapy in patients with Parkinson's diseaseThomas MüllerExpert Review of Neurotherapeutics|May 29, 2008
Role of homocysteine in the treatment of Parkinson's diseaseThomas MüllerExpert Opinion on Drug Metabolism & Toxicology|May 25, 2017
Pharmacokinetic drug evaluation of safinamide mesylate for the treatment of mid-to-late stage Parkinson's diseaseThomas MüllerNeurodegenerative Disease Management|September 8, 2016
Nondopaminergic therapy of motor and nonmotor symptoms in Parkinson's disease: a clinician's perspectiveThomas MüllerBerichte Zur Wissenschaftsgeschichte|December 13, 2006
[Medical expertise--the Zionist vision: medicine and physicians among the immigrants to Palestine/Israel]Thomas MüllerExpert Opinion on Pharmacotherapy|April 8, 2023
The role of istradefylline in the Parkinson's disease armamentariumThomas MüllerExpert Opinion on Drug Safety|February 14, 2015
The safety of istradefylline for the treatment of Parkinson's diseaseThomas MüllerExpert Opinion on Investigational Drugs|March 27, 2015
Valbenazine granted breakthrough drug status for treating tardive dyskinesiaThomas MüllerPageof 132